Loading candles…
Nephro Care India Ltd, incorporated in 2014 and headquartered in Kolkata, West Bengal, operates in the healthcare and renal healthcare industries. The company specializes in treating kidney-related diseases through clinical and diagnostic services, dialysis treatments, and transplant support, focusing on chronic kidney disease. Serving primarily Eastern India, Nephro Care India Ltd addresses the demand-supply gap in renal healthcare services in this region. The company’s business segments include healthcare services and kidney care services. There are no listed subsidiaries, founders, key management details, or stock exchange listings provided.
This page is a live market overview for NEPHRO CARE INDIA LIMITED (NEPHROCARE) on the NSE. As a listed security, NEPHRO CARE INDIA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NEPHROCARE before placing trades on tick2trade.
As of the latest feed, NEPHROCARE last traded at ₹75.8 on NSE, up ₹3.6 (4.99%) from the previous close of ₹72.2. Today's session range is ₹75.6 – ₹75.8, against a 52-week band of ₹50.05 – ₹183. Traded volume today stands at 25.20K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for NEPHROCARE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NEPHROCARE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NEPHRO CARE INDIA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NEPHROCARE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NEPHROCARE option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.